• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    More On TRL.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Trimel Pharmaceuticals Corp. (TRL.TO)

    -Toronto
    0.75 Down 0.01(1.32%) Apr 24, 3:33PM EDT
    Add to Portfolio
    Prev Close:0.76
    Open:0.76
    Bid:0.75
    Ask:0.76
    1y Target Est:N/A
    Beta:N/A
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:0.75 - 0.76
    52wk Range:0.31 - 0.92
    Volume:10,250
    Avg Vol (3m):201,017
    Market Cap:150.65M
    P/E (ttm):N/A
    EPS (ttm):-0.13
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Headlines

    » More Headlines for TRL.TO

    Key Statistics

    Forward P/E (1 yr):75.00
    P/S (ttm):35.40
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.04
    Quarterly EPS Est (Mar-15) :-0.01
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trimel Pharmaceuticals Corporation, a specialty pharmaceutical company, develops, distributes, and sells medications for male hypogonadism, female sexual dysfunction, and respiratory disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback